341. Berring Shaun E. Rifamycin-induced lupus syndrom / E. Bering Shaun,
D. Iseman Michall // Lancet. - 1997. - Vol. 349, № 9064. - P. 1521-1522.
342. Bestetti A. Improvement of the diagnostic value of synchronous
myocardial tomoscintigraphy in the assessment of radional myocardial perfusion /
A. Bestetti, A. Triulsi, C. Di Leo // Radiology Med. - 1999. - Vol. 97, № 1. - P.
48-53.
343. Betterige D.J. What is oxidative stress? / D.J. Betterige // Metabolism.
2000. Vol. 49 .-Supp l. l . - P . 3-8.
344. Bhagat N. Rifabutin-associated hypopyon uveitis in human
immunodeficiency virus-negative immunocompletent individuals / N. Bhagat,
R.W Read, N.A. Rao et al. // Ophtalmology. - 2001. - Vol. 8, № 4. - P. 750-752.
345. Brande P. Aging and hepatotoxicity of isoniazid and rifampin in
pulmonary tuberculosis / P. Brande // Am. J. Respir. Crit. Care Med. - 1995. - 11.
- Vol. 152, № 5 . - P . 1705-1708.
346. Brigger P. Segmentation of gated TL-Spect images and computation of
ejection fraction: a different approash / P. Brigger, G. Srinivasan et al. // J. Nucl.
Radional. - 1999. - Vol. 6, № 3. - P. 286-297.
347. Capastat® (capreomycin for injection) sulfate Dura Pharmaceuticals //
Prescribing information. - San Diego, CA, 1997.- 27 p.
348. Casolo G.C. Heart rate variability during the acute phase of myocardial
infarction / G. C. Casolo, P. Stroder, C. Signorini // Circulation. - 1992. - Vol. 85.
- P 2073-2079.
349. Cerati D. Influence of residual ischemia of heart rate variability after
myocardial infarction / D. Cerati, F. Nador, R. Maestry // Eur Heart J. - 1997. -
Vol. 18 .- P 78-83.
350. Chatterjee V.K.K. Ocular toxicity following ethambutol in standart
dosage / V.K.K. Chatterjee, D.R. Buchanan, A.J. Friedman // Brit. J. Dis. Chest. -
1986. - Vol. 80, № 3. - P. 288-291.
394
